Full text
PDFPage 1667
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alexandre C., Meunier P. J., Edouard C., Khairi R. A., Johnston C. C. Effects of ethane-1 hydroxy-1, 1-diphosphonate (5 mg/kg/day dose) on quantitative bone histology in Paget's disease of bone. Metab Bone Dis Relat Res. 1981;3(4-5):309–315. doi: 10.1016/0221-8747(81)90047-3. [DOI] [PubMed] [Google Scholar]
- Flora L., Hassing G. S., Cloyd G. G., Bevan J. A., Parfitt A. M., Villanueva A. R. The long-term skeletal effects of EHDP in dogs. Metab Bone Dis Relat Res. 1981;3(4-5):289–300. doi: 10.1016/0221-8747(81)90045-x. [DOI] [PubMed] [Google Scholar]
- Johnston C. C., Jr, Altman R. D., Canfield R. E., Finerman G. A., Taulbee J. D., Ebert M. L. Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP). Clin Orthop Relat Res. 1983 Jan-Feb;(172):186–194. [PubMed] [Google Scholar]
- Kanis J. A. Treatment of osteoporotic fracture. Lancet. 1984 Jan 7;1(8367):27–33. doi: 10.1016/s0140-6736(84)90191-0. [DOI] [PubMed] [Google Scholar]
- Nagant de Deuxchaisnes C., Dufour J. P., Devogelaer J. P., Huaux J. P., Esselinckx W. Etidronate and the risk of fractures. Lancet. 1985 Sep 14;2(8455):610–611. doi: 10.1016/s0140-6736(85)90607-5. [DOI] [PubMed] [Google Scholar]
- Preston C. J., Yates A. J., Beneton M. N., Russell R. G., Gray R. E., Smith R., Kanis J. A. Effective short term treatment of Paget's disease with oral etidronate. Br Med J (Clin Res Ed) 1986 Jan 11;292(6513):79–80. doi: 10.1136/bmj.292.6513.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rashid M., Khairi A., Johnston C., Jr Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP). Clin Orthop Relat Res. 1977;(127):94–105. [PubMed] [Google Scholar]